OSIS Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
OSIS is not a good buy right now for an impatient trader. Despite strong Q2 results and raised FY2026 non-GAAP EPS guidance, the near-term setup is unfavorable: momentum is still bearish (MACD worsening), price is sitting right on key support (~270), and options flow is heavily put-skewed (very high put/call volume). This combination suggests downside/volatility risk is still elevated before a cleaner rebound setup appears.
Pre-market price (268) is below the pivot (280.95) and pressing into the first support zone (S1 ~270.01); the next support is S2 ~263.26. Trend/momentum remains weak: MACD histogram is negative (-1.91) and expanding lower, which typically signals a continuing downside impulse rather than a confirmed reversal. RSI(6) at ~31.7 is near oversold and can support a bounce attempt, but with MACD still deteriorating and moving averages converging (no clear uptrend), the higher-probability read is ‘bearish-to-neutral’ until price reclaims ~271–272 and starts holding above the pivot area (281). Resistance levels to watch are ~291.9 (R1) and ~298.6 (R2).
revenue grew ~11% YoY to ~$464M and management raised FY2026 non-GAAP EPS guidance to $10.30–$10.
Security division revenue rose ~15% YoY, reinforcing the core growth engine. Recent order momentum (e.g., ~$30M naval communications order) supports backlog/visibility. Wall Street upside view exists: BofA reiterates Buy and lifted PT to $315, citing thematic tailwinds from increased U.S. border/security spending emphasis.
Near-term headwinds remain: delayed orders tied to the U.S. government shutdown and management flagged a Q3 revenue headwind of >$50M. Mexico security contract revenue fell ~50% (to ~$27M), indicating lumpiness/contract risk. Profitability quality is mixed: gross margin dropped to ~32.67% (down ~6.79% YoY). From a trading perspective, momentum is still bearish (MACD weakening) and options flow is strongly put-skewed, suggesting the market expects more downside/volatility before stabilizing. No notable supportive insider/hedge fund trend was reported (both ‘Neutral’).
Latest quarter: FY2026/Q2. Revenue rose to ~$464.1M (+10.54% YoY), showing healthy top-line growth. Net income increased to ~$38.7M (+2.33% YoY), but EPS was ~$2.22 (flat YoY), implying earnings growth is not keeping pace with revenue. Gross margin declined to ~32.67% (-6.79% YoY), a key negative trend (pressure on profitability/operating leverage). Operating expenses improved as a % of sales (down to ~15.1% from ~16.8%), which is a positive efficiency signal, but margin compression keeps the quality of growth mixed.
Recent analyst actions are mixed but improving on the bullish side: BofA (2025-11-05) kept a Buy and raised its price target to $315 from $265, highlighting thematic security/border spending tailwinds. JPMorgan (2025-11-03) kept a Neutral and raised its price target modestly to $255 from $242 after earnings. Net takeaway: Wall Street pros see strong long-term demand drivers (security spending, order flow), while cons center on near-term lumpiness (government-related delays, contract variability) and margin pressure. Politicians/congress trading: no recent congress trading data available, and no notable politician/influential-figure trading was provided.
